Rodent model of metabolic dysfunction‐associated fatty liver disease: a systematic review

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works

Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey

Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119 · see citing works

Non-alcoholic fatty liver disease

Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789 · see citing works

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

Riazi, K., Azhari, H., Charette, J. H., Underwood, F. E., King, J. A., Afshar, E. E., Swain, M. G., Congly, S. E., Kaplan, G. G., & Shaheen, A.-A. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00165-0 · Cited by 2,246 · see citing works

Nonalcoholic Steatohepatitis

Sheka, A. C., Adeyi, O. A., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,398 · see citing works

Microscale culture of human liver cells for drug development

Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · see citing works

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease

Cotter, T. G., & Rinella, M. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,205 · see citing works

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

Li, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., Fujii, H., Wu, Y., Kam, L. Y., Ji, F., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30039-1 · Cited by 1,036 · see citing works

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941 · see citing works

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

Ye, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., Yang, H., Liu, C., Kam, L. Y., Tan, X. X. E., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30077-7 · Cited by 925 · see citing works

Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis

Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870 · see citing works

Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association

Duell, P. B., Welty, F. K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D. E., Horton, J. D., Pressman, G. S., Toth, P. P., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000153 · Cited by 727 · see citing works

Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714 · see citing works

Nonalcoholic fatty liver disease

Brunt, E., Wong, V., Nobili, V., Day, C., Sookoian, S., Maher, J., Bugianesi, E., Sirlin, C., Neuschwander-Tetri, B., & Rinella, M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.80 · Cited by 591 · see citing works

A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer

Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583 · see citing works

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity

Tilg, H., Adolph, T., Dudek, M., & Knolle, P. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 495 · see citing works

Preclinical models of non-alcoholic fatty liver disease

Santhekadur, P. K., Kumar, D. P., & Sanyal, A. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.031 · Cited by 380 · see citing works

Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis

Farrell, G., Schattenberg, J. M., Leclercq, I., Yeh, M. M., Goldin, R., Teoh, N., & Schuppan, D. (2019) · Hepatology · doi:10.1002/hep.30333 · Cited by 313 · see citing works

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)

Kanuri, G., & Bergheim, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611963 · Cited by 293 · see citing works

Obese and diabetic <i>db</i>/<i>db</i> mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin

Sahai, A., Malladi, P., Pan, X., Paul, R., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2004 · Cited by 290 · see citing works

Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies

Kirsch, R., Clarkson, V., Shephard, E., Marais, D. A., Jaffer, M. A., WOODBURNE, V. E., Kirsch, R. E., & Hall, P. D. L. Μ. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03198.x · Cited by 263 · see citing works

From NAFLD to MAFLD: when pathophysiology succeeds

Tilg, H., & Effenberger, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0316-6 · Cited by 258 · see citing works

Fructose and hepatic insulin resistance

Softic, S., Stanhope, K. L., Boucher, J., Divanovic, S., Lanaspa, M. A., Johnson, R. J., & Kahn, C. R. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1711360 · Cited by 255 · see citing works

Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients

Teufel, A., Itzel, T., Erhart, W., Brosch, M., Wang, X. Y., Kim, Y. O., von Schönfels, W., Herrmann, A., Brückner, S., Stickel, F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.051 · Cited by 229 · see citing works

Long-term functional maintenance of primary human hepatocytes in vitro

Xiang, C., Du, Y., Meng, G., Soon Yi, L., Sun, S., Song, N., Zhang, X., Xiao, Y., Wang, J., Yi, Z., et al. (2019) · Science · doi:10.1126/science.aau7307 · Cited by 223 · see citing works

Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine #

Lee, L., Alloosh, M., Saxena, R., Alstine, W. V., Watkins, B. A., Klaunig, J. E., Sturek, M. S., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.22904 · Cited by 211 · see citing works

Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats

Xu, Z., Fan, J., Ding, X., Qiao, L., & Wang, G. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0815-3 · Cited by 196 · see citing works

A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD

Im, Y. R., Hunter, H., de Gracia Hahn, D., Duret, A., Cheah, Q., Dong, J., Fairey, M., Hjalmarsson, C., Li, A., Lim, H. K., et al. (2021) · Hepatology · doi:10.1002/hep.31897 · Cited by 195 · see citing works

Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production

Myojin, Y., Hikita, H., Sugiyama, M., Sasaki, Y., Fukumoto, K., Sakane, S., Makino, Y., Takemura, N., Yamada, R., Shigekawa, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.12.015 · Cited by 178 · see citing works

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

Lazarus, J. V., Ekstedt, M., Marchesini, G., Mullen, J., Novak, K., Pericàs, J. M., Roel, E., Romero‐Gómez, M., Ratziu, V., Tacke, F., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.027 · Cited by 167 · see citing works

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

Martin, L., Ribas, R., Simigdala, N., Schuster, E. F., Pancholi, S., Tenev, T., Gellert, P., Buluwela, L., Harrod, A., Thornhill, A. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01864-y · Cited by 156 · see citing works

Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours

Nwosu, Z. C., Battello, N., Rothley, M., Piorońska, W., Sitek, B., Ebert, M. P. A., Hofmann, U., Sleeman, J. P., Wölfl, S., Meyer, C., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0872-6 · Cited by 155 · see citing works

A critical perspective on 3D liver models for drug metabolism and toxicology studies

Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138 · see citing works

Small rodent models of atherosclerosis

Zhao, Y., Qu, H., Wang, Y., Xiao, W., Zhang, Y., & Shi, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110426 · Cited by 137 · see citing works

Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol

Eng, J., & Estall, J. L. (2021) · Cells · doi:10.3390/cells10071805 · Cited by 136 · see citing works

Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism

Nagarajan, S. R., Paul-Heng, M., Krycer, J. R., Fazakerley, D. J., Sharland, A. F., & Hoy, A. J. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00365.2018 · Cited by 132 · see citing works

CD44 is a key player in non-alcoholic steatohepatitis

Patouraux, S., Rousseau, D., Bonnafous, S., Lebeaupin, C., Luci, C., Canivet, C. M., Schneck, A.-S., Bertola, A., Saint‐Paul, M., Iannelli, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.003 · Cited by 131 · see citing works

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

Boland, M. L., Oró, D., Tølbøl, K. S., Thrane, S. T., Nielsen, J. C., Cohen, T. S., Tabor, D. E., Fernandes, F., Tovchigrechko, A., Veidal, S. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4904 · Cited by 129 · see citing works

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research

Flessa, C., Ansari, N. N., Kyrou, I., Leca, B. M., Lianou, M., Chatzigeorgiou, A., Kaltsas, G., Kassi, E. N., & Randeva, H. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415791 · Cited by 129 · see citing works

Synthetic LXR agonists increase LDL in CETP species

Groot, P. H. E., Pearce, N. J., Yates, J. W., Stocker, C. J., Sauermelch, C. F., Doe, C. P. A., Willette, R. N., Olzinski, A. R., Peters, T., d'Epagnier, D. L., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500116-jlr200 · Cited by 120 · see citing works

Rodent Models of Nonalcoholic Fatty Liver Disease

Zhong, F., Zhou, X., Xu, J., & Gao, L. (2019) · Digestion · doi:10.1159/000501851 · Cited by 119 · see citing works

Liver-Specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice

Gandhi, C. R., Chaillet, J. R., Nalesnik, M. A., Kumar, S., Dangi, A., Demetris, A. J., Ferrell, R. E., Wu, T., Divanovic, S., Stankeiwicz, T., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.008 · Cited by 99 · see citing works

Hepatocyte‐specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up‐regulation of Bach1, an Nrf2 repressor

Ka, S., Bang, I. H., Bae, E. J., & Park, B. (2017) · The FASEB Journal · doi:10.1096/fj.201700098rr · Cited by 98 · see citing works

Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression

Sefried, S., Häring, H., Weigert, C., & Eckstein, S. S. (2018) · Royal Society Open Biology · doi:10.1098/rsob.180147 · Cited by 97 · see citing works

CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice

Her, Z., Tan, J. H. L., Lim, Y.-S., Tan, S. Y., Chan, X., Tan, W., Liu, M., Yong, K. S. M., Lai, F., Ceccarello, E., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580968 · Cited by 90 · see citing works

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

Döcke, S., Lock, J. F., Birkenfeld, A. L., Hoppe, S., Lieske, S., Rieger, A., Raschzok, N., Sauer, I. M., Florian, S., Osterhoff, M. A., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0112 · Cited by 87 · see citing works

LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis

Guo, X., Gao, M., Wang, Y., Lin, X., Liu, Y., Cong, N., An, X., Wang, F., Qu, K., Yu, L., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.013 · Cited by 83 · see citing works

Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD

Donné, R., Saroul-Aïnama, M., Cordier, P., Hammoutène, A., Kaboré, C., Stadler, M., Nemazanyy, I., Galy–Fauroux, I., Herrag, M., Riedl, T., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.06.003 · Cited by 81 · see citing works

A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet

Alshawsh, M. A., Alsalahi, A., Alshehade, S. A., Saghir, S. A. M., Ahmeda, A. F., Al Zarzour, R. H., & Mahmoud, A. M. (2022) · Molecules · doi:10.3390/molecules27030858 · Cited by 81 · see citing works

Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model

Elbadawy, M., Yamanaka, M., Goto, Y., Hayashi, K., Tsunedomi, R., Hazama, S., Nagano, H., Yoshida, T., Shibutani, M., Ichikawa, R., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119823 · Cited by 79 · see citing works

The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model

Schwabl, P., Hambruch, E., Budas, G. R., Supper, P., Burnet, M., Liles, J. T., Birkel, M., Brusilovskaya, K., Königshofer, P., Peck-Radosavljevic, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010060 · Cited by 70 · see citing works

The association of hepatic apoprotein and lipid metabolism in hamsters and rats

Liu, G. L., Fan, L.-M., & Redinger, R. N. (1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90263-c · Cited by 65 · see citing works

Transgenic expression of human neutrophil peptide‐1 enhances hepatic fibrosis in mice fed a choline‐deficient, L‐amino acid–defined diet

Ibusuki, R., Uto, H., Arima, S., Mawatari, S., Setoguchi, Y., Iwashita, Y., Hashimoto, S., Maeda, T., Tanoue, S., Kanmura, S., et al. (2013) · Liver International · doi:10.1111/liv.12203 · Cited by 61 · see citing works

Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs

Tveden‐Nyborg, P., Birck, M. M., Ipsen, D. H., Thiessen, T., Feldmann, L. D. B., Lindblad, M. M., Jensen, H. E., & Lykkesfeldt, J. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.001 · Cited by 56 · see citing works

Gender and strain-specific differences in the development of steatosis in rats

Stöppeler, S., Palmes, D., Fehr, M., Hölzen, J. P., Zibert, A., Siaj, R., Schmidt, H., Hu, S., & Bahde, R. (2013) · Laboratory Animals · doi:10.1177/0023677212473717 · Cited by 56 · see citing works

Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH

Pompili, S., Vetuschi, A., Gaudio, E., Tessitore, A., Capelli, R., Alesse, E., Latella, G., Sferra, R., & Onori, P. (2020) · Nutrition · doi:10.1016/j.nut.2020.110782 · Cited by 56 · see citing works

Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model

Padilla, J., Osman, N. M., Bissig-Choisat, B., Grimm, S. L., Qin, X., Major, A. M., Yang, L., Lopez-Terrada, D. H., Coarfa, C., Li, F., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.10.018 · Cited by 56 · see citing works

Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line

Korch, C., Hall, E. M., Dirks, W. G., Ewing, M., Faries, M., Varella‐Garcia, M., Robinson, S., Storts, D., Turner, J. A., Wang, Y., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31067 · Cited by 53 · see citing works

Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non‐Alcoholic Steatohepatitis

Ipsen, D. H., Rolin, B. C., Rakipovski, G., Skovsted, G. F., Madsen, A., Kolstrup, S. H., Schou‐Pedersen, A. M. V., Skat‐Rørdam, J., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13082 · Cited by 53 · see citing works

Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis

Guo, S., Feng, Y., Zhu, X., Zhang, X., Wang, H., Wang, R., Zhang, Q., Li, Y., Ren, Y., Gao, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41832-3 · Cited by 51 · see citing works

State-of-the-art liver disease research using liver-on-a-chip

Deguchi, S., & Takayama, K. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00248-0 · Cited by 50 · see citing works

Rodent nutritional model of steatohepatitis: Effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency

Kirsch, R., Clarkson, V., Verdonk, R. C., Marais, A. D., Shephard, E., Ryffel, B., & Hall, P. D. L. Μ. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04220.x · Cited by 50 · see citing works

High fat diets and pathology in the guinea pig. Atherosclerosis or liver damage?

Ye, P., Cheah, I. K.-M., & Halliwell, B. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.008 · Cited by 49 · see citing works

Mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: Roles of hepatic MTP and triglyceride secretion

Gao, S., He, L., Ding, Y., & Liu, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.114 · Cited by 49 · see citing works

Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters

Bhathena, J., Martoni, C., Kulamarva, A. G., Tomaro-Duchesneau, C., Malhotra, M., Paul, A., Urbanska, A. M., & Prakash, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058394 · Cited by 48 · see citing works

Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion

Maciejewska, D., Łukomska, A., Dec, K., Skonieczna‐Żydecka, K., Gutowska, I., Skórka-Majewicz, M., Styburski, D., Misiakiewicz-Has, K., Pilutin, A., Palma, J., et al. (2019) · Diagnostics · doi:10.3390/diagnostics9040205 · Cited by 45 · see citing works

The effects of alpha lipoic acid on liver cells damages and apoptosis induced by polyunsaturated fatty acids

Dağıstanlı, F. K., Tanrıverdi, G., Altınok, A., Özyazgan, S., & Öztürk, M. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.11.026 · Cited by 44 · see citing works

Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis

Zhao, D., Shi, H., Zhao, M., Zhang, X., Huang, W. Y., Wang, Y., Zheng, L., Xian, X., & Liu, C. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.003 · Cited by 43 · see citing works

Type of Steatosis Influences Microcirculation and Fibrogenesis in Different Rat Strains

Rosenstengel, S., Stöppeler, S., Bahde, R., Spiegel, H.-U., & Palmes, D. (2011) · Journal of Investigative Surgery · doi:10.3109/08941939.2011.586094 · Cited by 42 · see citing works

Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model

Briand, F., Brousseau, E., Quinsat, M., Burcelin, R., & Sulpice, T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.021 · Cited by 41 · see citing works

Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease

Caddeo, A. M., & Romeo, S. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0438 · Cited by 41 · see citing works

A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation

Pelz, S., Stock, P., Brückner, S., & Christ, B. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.005 · Cited by 39 · see citing works

The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice

Wang, Y., Fang, W., Wei, J., Wang, T., Wang, N., Ma, J., & Shi, M. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.08.010 · Cited by 39 · see citing works

Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high‐fat diet fed mice

Zamani‐Garmsiri, F., Ghasempour, G., Aliabadi, M., Hashemnia, S. M. R., Emamgholipour, S., & Meshkani, R. (2020) · IUBMB Life · doi:10.1002/iub.2424 · Cited by 39 · see citing works

Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters

Briand, F., Maupoint, J., Brousseau, E., Breyner, N. M., Bouchet, M., Costard, C., Lesté-Lasserre, T., Petitjean, M. M., Chen, L., Chabrat, A., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154707 · Cited by 36 · see citing works

A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

Ge, M., Niu, W., Ren, J., Cai, S., Yu, D., Liu, H., Zhang, N., Zhang, Y., Wang, Y., Shao, R., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0195-3 · Cited by 35 · see citing works

A new method to induce nonalcoholic steatohepatitis (NASH) in mice

Savari, F., Mard, S. A., Badavi, M., Rezaie, A., & Gharib-Naseri, M. K. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1041-x · Cited by 35 · see citing works

2D and 3D liver models

Saxton, S. H., & Stevens, K. R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.022 · Cited by 35 · see citing works

Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high‐fat diet in the genetically diverse Collaborative Cross mouse model

de Conti, A., Tryndyak, V., Willett, R. A., Borowa‐Mazgaj, B., Watson, A., Patton, R. E., Khare, S., Muskhelishvili, L., Olson, G. R., Avigan, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000194r · Cited by 33 · see citing works

Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice

Lin, D., Sun, Q., Liu, Z., Pan, J., Zhu, J., Wang, S., Jia, S., Zheng, M., Li, X., & Gong, F. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.087 · Cited by 33 · see citing works

Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury

Shi, Q., Arefin, A., Ren, L., Papineau, K. S., Barnette, D. A., Schnackenberg, L. K., Hawes, J. J., Avigan, M., Mendrick, D. L., Ewart, L. C., et al. (2022) · Current Protocols · doi:10.1002/cpz1.478 · Cited by 33 · see citing works

Intracellular C3 prevents hepatic steatosis by promoting autophagy and very‐low‐density lipoprotein secretion

Li, Y., Sha, Y., Wang, H., He, L., Li, L., Wen, S., Sheng, L., Hu, W., & Zhou, H. (2021) · The FASEB Journal · doi:10.1096/fj.202100856r · Cited by 31 · see citing works

Potential use of C-phycocyanin in non-alcoholic fatty liver disease

Ma, P., Huang, R., Jiang, J., Ding, Y., Li, T., & Ou, Y. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.001 · Cited by 30 · see citing works

The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research

Chiara, F. D., Ferret-Miñana, A., & Ramón‐Azcón, J. (2021) · Biomedicines · doi:10.3390/biomedicines9030248 · Cited by 30 · see citing works

Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease

Oates, J. R., Sawada, K., Giles, D. A., Alarcon, P. C., Damen, M. S. M. A., Szabo, S., Stankiewicz, T. E., Moreno‐Fernandez, M. E., & Divanovic, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1095132 · Cited by 29 · see citing works

Dietary Cholic Acid Exacerbates Liver Fibrosis in NASH Model of Sprague–Dawley Rats Fed a High-Fat and High-Cholesterol Diet

Ichimura‐Shimizu, M., Watanabe, S., Kashirajima, Y., Nagatomo, A., Wada, H., Tsuneyama, K., & Omagari, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169268 · Cited by 28 · see citing works

Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency

Bas-Prior, J. M. D., Rodríguez‐Santiago, B., Puiggròs, F., Mariné, S., Rodriguez, M. A., Moriña, D., Armengol, L., Caimari, A., & Arola, L. (2017) · Clinical Science · doi:10.1042/cs20171039 · Cited by 27 · see citing works

Animal Models Correlating Immune Cells for the Development of NAFLD/NASH.

Iyer, S., Upadhyay, P., Majumdar, S., & Nagarajan, P. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.06.004 · Cited by 26 · see citing works

NF-E2-related factor 2 deletion facilitates hepatic fatty acids metabolism disorder induced by high-fat diet via regulating related genes in mice

Wang, X., Li, C., Xu, S. Z., Ishfaq, M., & Zhang, X. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.06.011 · Cited by 26 · see citing works

Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway

Lin, M., Dai, W., Scott, M. J., Li, R., Zhang, Y.-Q., Yang, Y., Chen, L.-Z., & Huang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22163 · Cited by 26 · see citing works

Pathophysiological Analysis of the Progression of Hepatic Lesions in STAM Mice

Saito, T., MURAMATSU, M., ISHII, Y., Saigo, Y., Konuma, T., Toriniwa, Y., Miyajima, K., & Ohta, T. (2017) · Physiological Research · doi:10.33549/physiolres.933592 · Cited by 26 · see citing works

New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease

Maeso‐Díaz, R., Boyer‐Díaz, Z., Lozano, J. J., Ortega‐Ribera, M., Peralta, C., Bosch, J., & Gracia‐Sancho, J. (2019) · Cells · doi:10.3390/cells8091062 · Cited by 25 · see citing works

Modelling fatty liver disease with mouse liver-derived multicellular spheroids

van Os, E. A., Cools, L., Eysackers, N., Szafranska, K., Smout, A., Verhulst, S., Reynaert, H., McCourt, P., Mannaerts, I., & van Grunsven, L. A. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121817 · Cited by 25 · see citing works

Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction

Zhang, X., Lin, Y., Lin, S., Li, C., Gao, J., Feng, Z., Wang, J., Zhang, J., Zhang, H., Zhang, Y., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10068-4 · Cited by 24 · see citing works

Experimental models of fatty liver diseases: Status and appraisal

Wang, H., Shen, H., Seo, W., & Hwang, S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000200 · Cited by 24 · see citing works

Silicon Alleviates Nonalcoholic Steatohepatitis by Reducing Apoptosis in Aged Wistar Rats Fed a High–Saturated Fat, High-Cholesterol Diet

Garcimartín, A., López‐Oliva, M. E., Santos-López, J. A., García-Fernández, R. A., Macho‐González, A., Bastida, S., Benedı́, J., & Sánchez-Muniz, F. J. (2017) · Journal of Nutrition · doi:10.3945/jn.116.243204 · Cited by 23 · see citing works

Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis

Etienne, Q., Lebrun, V., Komuta, M., Navez, B., Thissen, J., Leclercq, I. A., & Lanthier, N. (2022) · Metabolites · doi:10.3390/metabo12070625 · Cited by 23 · see citing works

F atty liver S hionogi‐ob/ob mouse: A new candidate for a non‐alcoholic steatohepatitis model

Sugihara, T., Koda, M., Kishina, M., Kato, J., Tokunaga, S., Matono, T., Ueki, M., & Murawaki, Y. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01101.x · Cited by 22 · see citing works

Protective effects of maslinic acid on high fat diet-induced liver injury in mice

Li, T., Wang, H., Dong, S., Liang, M., Ma, J., Jiang, X., & Yu, W. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120634 · Cited by 22 · see citing works

NASH-inducing Diets in Göttingen Minipigs

Pedersen, H. D., Galsgaard, E. D., Christoffersen, B. Ø., Cirera, S., Holst, D., Fredholm, M., & Latta, M. R. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.09.004 · Cited by 21 · see citing works

Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments

Wang, J., Liu, H., Xie, G., Cai, W., & Xu, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10872 · Cited by 21 · see citing works

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Han, D., Xu, K., Jin, Z., Xu, Y., Li, Y., Wang, L., Cao, Q., Kim, K.-P., Ryu, D. H., Hong, K., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85145 · Cited by 21 · see citing works

Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times

Acosta-Cota, S. D. J., Aguilar‐Medina, M., Ramos‐Payán, R., Ruiz-Quiñónez, A. K., Romero-Quintana, J. G., Montes‐Ávila, J., Rendón-Maldonado, J. G., Sánchez‐López, A., Centurión, D., & Osuna‐Martínez, U. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0353 · Cited by 20 · see citing works

Liver Protein Expression in NASH Mice on a High-Fat Diet: Response to Multi-Mineral Intervention

Varani, J., McClintock, S. D., Knibbs, R. N., Harber, I., Zeidan, D., Jawad-Makki, M. A. H., & Aslam, M. N. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.859292 · Cited by 20 · see citing works

Increased risk for microvascular outcomes in NAFLD—A nationwide, population‐based cohort study

Ebert, T., Widman, L., Stenvinkel, P., & Hagström, H. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13673 · Cited by 20 · see citing works

Molecular cloning and functional expression of cDNA encoding the pig plasma phospholipid transfer protein

Pussinen, P. J., Olkkonen, V. M., Jauhiainen, M., & Ehnholm, C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37429-0 · Cited by 19 · see citing works

Hepatocyte- or macrophage-specific SREBP-1a deficiency in mice exacerbates methionine- and choline-deficient diet-induced nonalcoholic fatty liver disease

Araki, M., Nakagawa, Y., Saito, H., Yamada, Y., Han, S., Mizunoe, Y., Ohno, H., Miyamoto, T., Sekiya, M., Matsuzaka, T., et al. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00090.2022 · Cited by 18 · see citing works

Comparison of Animal Models for the Study of Nonalcoholic Fatty Liver Disease

Zheng, Q. R., Zhu, M., Zeng, X., Liu, W., Fu, F., Li, X., Liao, G., Lu, Y., & Chen, Y. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2023.100129 · Cited by 18 · see citing works

Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis

Wu, Y., Xu, M., Cao, Z., Yang, C., Wang, J., Wang, B., Liu, J., Wang, Y., Xian, X., Zhang, F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235936 · Cited by 18 · see citing works

Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis

Kim, M., Lee, Y., Bae, M., Kang, H., Pham, T. X., Hu, S., Lee, J., & Park, Y. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108463 · Cited by 17 · see citing works

Non‐alcoholic steatohepatitis‐associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge

Amano, Y., Shimizu, F., Yasuno, H., Harada, A., Tsuchiya, S., Isono, O., Nagabukuro, H., & Tozawa, R. (2016) · Hepatology Research · doi:10.1111/hepr.12709 · Cited by 15 · see citing works

Role of liquid fructose/sucrose in regulating the hepatic transcriptome in a high-fat Western diet model of NAFLD

Luo, Y., Woodie, L. N., Graff, E. C., Zhang, J., Fowler, S., Wang, X., Wang, X., O’Neill, A. M., & Greene, M. W. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109174 · Cited by 15 · see citing works

Opisthorchis viverrini Infection Augments the Severity of Nonalcoholic Fatty Liver Disease in High-Fat/High-Fructose Diet–Fed Hamsters

Chaidee, A., Onsurathum, S., Intuyod, K., Haonon, O., Pannangpetch, P., Pongchaiyakul, C., Pinlaor, P., Pairojkul, C., Welbat, J. U., Ittiprasert, W., et al. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0442 · Cited by 15 · see citing works

Selective Hepatic Cbs Knockout Aggravates Liver Damage, Endothelial Dysfunction and ROS Stress in Mice Fed a Western Diet

Lambooy, S., Heida, A., Joschko, C. P., Nakládal, D., van Buiten, A., Kloosterhuis, N., Huijkman, N., Gerding, A., van de Sluis, B., Henning, R. H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087019 · Cited by 14 · see citing works

Thermoneutral housing promotes hepatic steatosis in standard diet-fed C57BL/6N mice, with a less pronounced effect on NAFLD progression upon high-fat feeding

Horakova, O., Sistilli, G., Kalendová, V., Bardová, K., Mitrovic, M., Čajka, T., Irodenko, I., Janovská, P., Lackner, K., Kopecký, J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205703 · Cited by 14 · see citing works

High fat high sucrose diet-induced dyslipidemia in guinea pigs

Muller, C. R., Williams, A. T., Eaker, A. M., dos Santos, F., Palmer, A. F., & Cabrales, P. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00013.2021 · Cited by 14 · see citing works

Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis

Yamada, T., Kashiwagi, Y., Rokugawa, T., Kato, H., Konishi, H., Hamada, T., Nagai, R., Masago, Y., Itoh, M., Suganami, T., et al. (2018) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2018.11.013 · Cited by 13 · see citing works

Comparative study of liver injury induced by high-fat methionine- and choline-deficient diet in ICR mice originating from three different sources

Lee, S., Kwak, J., Kim, S. H., Jeong, T. B., Son, S. W., Kim, J.-H., Lim, Y., Cho, J., Hwang, D. Y., Kim, K., et al. (2019) · Laboratory Animal Research · doi:10.1186/s42826-019-0016-y · Cited by 13 · see citing works

Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing Tools

Kim, U., Kim, N., & Shin, H. Y. (2020) · Cells · doi:10.3390/cells9122572 · Cited by 13 · see citing works

Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease

Park, Y., Thadasina, D., Bolujo, I., Isidan, A., Cross-Najafi, A. A., Lopez, K., Li, P., Dahlem, A. M., Kennedy, L. L., Sato, K., et al. (2022) · Seminars in Liver Disease · doi:10.1055/a-1934-5588 · Cited by 13 · see citing works

Longitudinal comparison ofStreptococcus mutans-induced aggravation of non-alcoholic steatohepatitis in mice

Naka, S., Wato, K., Hatakeyama, R., Okawa, R., Nomura, R., & Nakano, K. (2018) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1428005 · Cited by 13 · see citing works

Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters

Briand, F., Sencio, V., Robil, C., Heumel, S., Deruyter, L., Machelart, A., Barthelemy, J., Bogard, G., Hoffmann, E., Infanti, F., et al. (2022) · Viruses · doi:10.3390/v14092067 · Cited by 12 · see citing works

Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model

Nagahara, R., Matono, T., Sugihara, T., Matsuki, Y., Yamane, M., Okamoto, T., Miyoshi, K., Nagahara, T., Okano, J., Koda, M., et al. (2019) · Yonago acta medica · doi:10.33160/yam.2019.03.006 · Cited by 12 · see citing works

Modelling Nonalcoholic Steatohepatitis In Vivo—A Close Transcriptomic Similarity Supports the Guinea Pig Disease Model

Skat‐Rørdam, J., Ipsen, D. H., Seemann, S. E., Latta, M. R., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091198 · Cited by 11 · see citing works

Genetically-engineered hamster models: applications and perspective in dyslipidemia and atherosclerosis-related cardiovascular disease

Liu, G., Lai, P., Guo, J., Wang, Y.-H., & Xian, X. (2021) · Medical Review · doi:10.1515/mr-2021-0004 · Cited by 11 · see citing works

Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice

Nagumalli, S. K., Willett, R. A., de Conti, A., Tryndyak, V., Avigan, M., da Costa, G. G., Beland, F. A., Rusyn, I., & Pogribny, I. P. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109108 · Cited by 11 · see citing works

A high-trans fat, high-carbohydrate, high-cholesterol, high-cholate diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response

Zhang, Q., Jin, Y., Xin, X., An, Z., Hu, Y., Li, Y., & Feng, Q. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00749-w · Cited by 11 · see citing works

Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis

Pedersen, K., Ipsen, D. H., Skat‐Rørdam, J., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2023) · Nutrients · doi:10.3390/nu15112445 · Cited by 8 · see citing works

[Effect of butylphthalide on blood-brain barrier after cerebral hemorrhage in SD rats and the mechanisms].

Qiu, K., Deng, S., Liu, H., You, H., Qiang, L., & Lu, W. (2019) · PubMed · doi:10.11817/j.issn.1672-7347.2019.190017 · Cited by 8 · see citing works

Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model

Saito, T., Toriniwa, Y., Ishii, Y., Uemura, A., Miyajima, K., Uno, K., Shirai, Y., Nakae, D., & Ohta, T. (2018) · Journal of Toxicologic Pathology · doi:10.1293/tox.2018-0016 · Cited by 7 · see citing works

Cafeteria diet from birth to adulthood promotes hepatic steatosis and redox imbalance in Wistar rats

Gomes, L. F., Costa, S. A. M., Rocha‐Gomes, A., Teixeira, A. E., da Silva, A. A., Lessa, M. R., Pinto, N. A. V. D., Seixas, S. R. S., & Riul, T. R. (2020) · Nutrition & Food Science · doi:10.1108/nfs-05-2020-0191 · Cited by 7 · see citing works

Culture of Mouse Liver Ductal Organoids

Yan, J., Tai, Y., & Zhou, H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2128-8_11 · Cited by 6 · see citing works

Heparanase Inhibition Prevents Liver Steatosis in E0 Mice

Kinaneh, S., Hijaze, W., Mansour-Wattad, L., Hammoud, R. A., Zaidani, H., Kabala, A., & Hamoud, S. (2021) · Journal of Clinical Medicine · doi:10.2139/ssrn.3959681 · Cited by 5 · see citing works

Establishment and metabonomics analysis of nonalcoholic fatty liver disease model in golden hamster

Zhao, C.-Z., Jiang, L., Li, W., Wu, G., Chen, J., Dong, L.-H., Li, M., Jiang, W., Zhu, J.-X., Gao, Y., et al. (2022) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2021-0201 · Cited by 5 · see citing works

Efficacy of fibroblast growth factor 21 in non‐alcoholic fatty liver disease in guinea pigs

Klæbel, J. H., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13705 · Cited by 4 · see citing works

Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?

Türkay, R., Aydin, A. F., Bingül, İ., Küçükgergin, C., Dogan-Ekici, I., Hocaoğlu, E., İnci, E., Bakır, B., & Uysal, M. (2017) · Ultrasound Quarterly · doi:10.1097/ruq.0000000000000286 · Cited by 4 · see citing works

Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Rhesus Monkeys Provides the First Animal Model that Accurately Reflects the Human Condition

HANSEN, B. C., Liang, Z., Sun, F., Yang, Z., Tang, C., Chen, Z., Shen, Y., Yao, Z., Wu, M., Chen, Y., et al. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.895.6 · Cited by 4 · see citing works

Human hepatocyte organoids model early NAFLD

Hindson, J. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00776-1 · Cited by 3 · see citing works

EFFICACY OF AN EXPERIMENTAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE BASED ON A HIGH-FAT DIET WITH CHOLESTEROL

Півторак, В. І., Sydorenko, B. V., Моnastyrskyi, V. М., Pivtorak, K. V., & Bulko, M. P. (2022) · World of Medicine and Biology · doi:10.26724/2079-8334-2022-2-80-222-226 · Cited by 3 · see citing works

Histopathological changes and onset of severe hepatic steatosis in rats fed a choline‑free diet

Karatzas, T., Sikalias, N., Mantas, D., Papalois, A. E., Alexiou, K., Mountzalia, L., & Kouraklis, G. P. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6385 · Cited by 3 · see citing works

L’émergence des modèles miniatures de foie gras humain en 3D générés en laboratoire

de l’Hortet, A. C., & Gilgenkrantz, H. (2020) · médecine/sciences · doi:10.1051/medsci/2020027 · Cited by 2 · see citing works

Retinoic acid induced 16 deficiency exacerbates high‐fat diet‐induced steatohepatitis in mice

Qian, C., Ding, C., Tang, H., Qi, Z., & Wang, W. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3542 · Cited by 2 · see citing works

Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice

Goon, M. D. M. E., Zulkanain, N. I., Kadir, S. H. S. A., Rahim, S. A., Mazlan, M., Latip, N. A., Aziz, M. A., & Noor, N. M. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.02.20 · Cited by 2 · see citing works

DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis

Yasuno, K., Kumagai, K., Iguchi, T., Tsuchiya, Y., Kai, K., & Mori, K. (2018) · Toxicologic Pathology · doi:10.1177/0192623318765909 · Cited by 1 · see citing works

Mechanisms and therapeutic insights into MASH-associated fibrosis

Zhu, Y., & Cai, B. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.09.004 · Cited by 22 · see citing works

Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota

Peng, S., Moran, M., Luo, P., Liu, J., Wang, J., & Chen, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030895 · Cited by 12 · see citing works

Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1

Lee, Y. H., Lee, J., Jeong, J., Park, K., Baik, B., Kwon, Y., Kim, K., Khim, K. W., Ji, H., Lee, J. Y., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156266 · Cited by 12 · see citing works

The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease

Kotlyarova, A., Iskrina, A., & Kotlyarov, S. (2026) · International journal of molecular sciences · doi:10.3390/ijms27083399 · Cited by 5 · see citing works

GLP-1 RAs for Treating Metabolic Dysfunction-Associated Steatosis Liver Disease: From GLP-1 Discovery to FDA Approval: A Comprehensive Narrative Review

Khalifa, O., & Arredouani, A. (2026) · Pharmaceuticals · doi:10.3390/ph19030408 · Cited by 5 · see citing works

Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool

Pérez-Escobar, J., Huerta-Álvarez, A., Castro‐Narro, G., Astudillo-Delgado, M. I., & Carpinteyro‐Espín, P. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i37.110164 · Cited by 3 · see citing works

Rebamipide Reprograms Hepatic Networks to Prevent and Reverse Metabolic-Dysfunction-Associated Steatotic Liver Disease: Multi-Omics Insights and Histological Validation

Nahas, H. H. A., Al-Dakhil, A., Mohamed, D. I., Yousef, T. A., Almaaty, A. H. A., EL-Deen, I. M. E.-D. I. M., Sembawa, H. A. M., & Saied, E. M. (2026) · Pharmaceuticals · doi:10.3390/ph19040559 · Cited by 3 · see citing works

Animal Models of Exercise and Cardiometabolic Disease

Dong, G., RYAN, T. E., & Esser, K. A. (2025) · Circulation Research · doi:10.1161/circresaha.124.325704 · Cited by 4 · see citing works

Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”

Ha, Y.-S., Kim, W. K., & Kim, S. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0036 · Cited by 2 · see citing works

Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice

Hara, T., Yamagami, H., Uemoto, R., Sekine, A., Kaneko, Y., Miyataka, K., Hori, T., Ichimura‐Shimizu, M., Funamoto, M., Harada, T., et al. (2025) · Antioxidants · doi:10.3390/antiox14070891 · Cited by 1 · see citing works

Protective effect of vitamin D on high-fat-diet-induced metabolic dysfunction-associated steatotic liver disease in mice

Mohamed, A. A., Hafez, W., El‐Feky, S. A., Khalil, M. G., Soliman, A. S., Nasraldin, K., Ibrahim, I. M. E.-H., Hegazy, H. A., Shaheen, W., Abbas, A. M., et al. (2025) · Steroids · doi:10.1016/j.steroids.2025.109718 · Cited by 1 · see citing works

Applications of Danio rerio as a model for studying NAFLD and NASH

Rafizadeh, M., Khazaei‐Poul, Y., Mohammadi, H., Khorramizadeh, M. R., Amoli, M. M., Larijani, B., & Ziai, S. A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01780-9 · Cited by 1 · see citing works

Silymarin-loaded phytosomal nanoparticles mitigate dyslipidemia, oxidative damage, and hepatic injury in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease in rats

Kattan, S. W., Almars, ‏. I., Tounsi, W. A., Turkistani, A. A., Mohamed, A. M. E. A., Elghareeb, M. M., Elmorsy, E. M., & Ali, S. H. E. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05004-z · Cited by 1 · see citing works

Modelos Animais de MASLD/NAFLD: uma revisão narrativa do estado atual e perspectivas futuras

dos Santos, G., Machado, F. D. C., Carmo, A. B. S., Sabedotti, A. I., Milléo, L. M., Cultz, L., Pizyblski, M. B., Lima, L. H. D. F., & Sturzeneker, M. C. S. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n12-108

Preclinical Models of Metabolic Dysfunction–Associated Steatotic Liver Disease for Therapeutic Testing

Cutrone, A. M., Yeh, H., Uygun, K., & Usta, O. B. (2026) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-081325-053420

Spirulina Preconditioning Attenuates Ischemia–Reperfusion Injury in a Steatotic Rat Liver Model

Baily, E., Mhalhel, K., Ahmed, S. B., Zaoualí, M. A., Montalbano, G., Lakhal-Naouar, I., Germanà, A., & Abdennebi, H. B. (2026) · Antioxidants · doi:10.3390/antiox15030390

Alternatives to animal models in gastroenterology and hepatology research

Gardey, E., Geisler, A. R., Löser, A., Stallmach, A., Kipp, A. P., Stefan Lorkowski, A., & Witt-Wallert, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1789616

Identification of Foxm1 as a critical regulator for metabolic dysfunction-associated steatotic liver disease by epigenomic and transcriptional profiling

Zeng, C., Wei, M., Li, H., Niu, F., Guo, Z., Li, L.-Y., Wu, M., & Chen, M.-K. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100325

Hesperidin Attenuates Experimental MASH by Modulating the Liver–Immune–Brain Axis: Integrated Evidence from Network Pharmacology and In Vivo Analysis

Yoo, S., Kim, J., Yoo, Y., & Lee, B.-C. (2026) · Nutrients · doi:10.3390/nu18091402

GCSH promotes MASH progression by regulating cuproptosis through the glycine–GSH metabolic pathway

Fu, X., Li, Y., Chen, J., Yin, B., Nasrin, M., Huo, R., & Tian, S. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.161

Human-Mouse Convergence in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mouse Model Selection and Non-Invasive Diagnostic Strategies

Bonente, D., Gargiulo, S., Livi, L., Gramanzini, M., Tamborrino, T., Gherardini, L. M., Inzalaco, G., Franci, L., Chiariello, M., & Barone, V. (2026) · Livers · doi:10.3390/livers6030046

Comparative Analysis of Classical and Emerging Experimental Animal Models of Liver Injury: A Comprehensive Review

Salman, I. N., Jabbar, R. K., Emad, I., Hassan, Z. A. A., Harbi, A. M., Khudhair, A. Y., Hussein, M. A. M., Hamid, A. M., Amir, M. A. A., Ali, M. W., et al. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70268

Capsinoids treatment reduces steatosis with consequent attenuation in the progression of metabolic dysfunction-associated steatotic liver disease in obese rats

Simmer, L. M., Nunes, F. M., Santos, K. V. D., Saiz, D. A. G., Miranda, K. O., Cordeiro, E. R., Boeloni, J. N., Bocalini, D. S., Leopoldo, A. S., & Lima‐Leopoldo, A. P. (2026) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2026e15127

Integrating fine needle aspiration and single-cell RNA sequencing for studying metabolic dysfunction-associated steatotic liver disease

Salomon, M. P., Golden‐Mason, L., Vorobyova, I., Kanel, G. C., Wang, Y., Wong, D., & Maretti-Mira, A. C. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1817738

Sulforaphane and Broccoli-Derived Preparations in Obesity and Obesity-Related Metabolic Dysfunction: Mechanistic Insights, Preclinical Evidence, and Clinical Perspectives

Poulios, E., Papadopoulou, S. Κ., Psara, E., Tasoulas, D., & Giaginis, C. (2026) · Pharmaceuticals · doi:10.3390/ph19081244

Mechanism-Oriented Model Selection in MASH Research: Insights from the iHFC Diet and TSOD/TSNO Mice

Ichimura‐Shimizu, M., Shao, W., Ogawa, H., Tachibana, S., & Tsuneyama, K. (2026) · Livers · doi:10.3390/livers6050089

Potential Effects of Naringenin on Hepatic Lipid Accumulation and Lipogenesis-Related Gene Expression in High-Fat Diet-Fed Rats

Alshehri, S. A., Osman, M. A., Alnafisah, G., Asiri, S., Arzoo, S., & Al‐Harbi, L. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219453

Experimental Rodent Models of Metabolic Dysfunction-Associated Fatty Liver Disease: Present Status and Future Perspective

Bhopale, K. K., & Srinivasan, M. P. (2026) · Livers · doi:10.3390/livers6030045 · Cited by 3 · see citing works

Preclinical Models of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): Merits and Translational Constraints

Tejasree*, J. A. M. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.22816088

Novel insights into metabolic‐associated steatotic liver disease preclinical models

Montero‐Vallejo, R., Maya‐Miles, D., Ampuero, J., Martı́n, F., Romero‐Gómez, M., & Gallego‐Durán, R. (2024) · Liver International · doi:10.1111/liv.15830 · Cited by 10 · see citing works

Preclinical Models of Metabolic Dysfunction–Associated Steatotic Liver Disease for Therapeutic Testing

Cutrone, A. M., Yeh, H., Uygun, K., & Usta, O. B. (2026) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-081325-053420

Progress in the Study of Animal Models of Metabolic Dysfunction-Associated Steatotic Liver Disease

Fu, Y., Hua, Y.-X., Alam, N., & Liu, E. (2024) · Nutrients · doi:10.3390/nu16183120 · Cited by 19 · see citing works